ArticleCell reports2026
Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer.
Kaylyn L Devlin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it